查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1471128

尿道感染感染檢測市場：按適應症、檢測套組、檢測、最終用戶分類 - 全球預測 2024-2030

Urinary Tract Infection Testing Market by Indication (Cystitis, Pyelonephritis, Urethritis), Test Kits (Home Test Kits, Laboratory Test Kits), Tests, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

尿道感染感染檢測市場規模預計2023年為14億美元，預計2024年將達14.7億美元，2030年將達到19.4億美元，複合年成長率為4.75%。

尿道感染(UTI) 檢測涉及一系列診斷程序，用於檢查泌尿道是否有感染。泌尿道是體內產生、儲存和排放尿液的系統的重要組成部分。這種感染主要由細菌、病毒和真菌等微生物引起，其中細菌是最常見的原因。尿道結石的檢查非常重要。這是因為這些感染疾病會引起嚴重不適，如果不及時治療，可能會導致嚴重的健康併發症。全球尿道感染的增加推動了對尿道感染(UTI) 檢測解決方案的需求。提高大眾對尿道感染相關症狀和風險的認知是尿道感染(UTI) 檢測解決方案的基礎。日益嚴重的抗生素抗藥性問題和尿道感染檢測的高成本正在阻礙市場成長。快速、可靠且易於使用的診斷測試開拓使泌尿道感染測試變得更容易，預計將創造市場成長機會。

主要市場統計
基準年[2023] 14億美元
預測年份 [2024] 14.7億美元
預測年份 [2030] 19.4億美元
複合年成長率（%） 4.75%

檢測：增加藥敏試驗的使用以避免處方抗生素

藥敏試驗是用來測定從尿道結石中分離出的細菌對不同抗生素的敏感性的測試方法。這項測試非常重要，因為它可以幫助您的醫生選擇最有效的抗生素來治療感染疾病。藥敏測試使醫療保健提供者能夠避免開出細菌具有抗藥性的抗生素，從而使他們能夠更有效地治療患者。尿液檢查是一種快速簡便的檢測，可分析尿液中是否存在某些感染疾病或腎臟疾病的指標。此測試檢查尿液的視覺、化學和微觀方面。此測試可以檢查尿道結石的早期跡象，例如白血球、紅血球、細菌或某些細菌產生的物質（例如亞硝酸鹽）的存在。當懷疑尿道結石時，尿液檢查通常是第一個檢查，因為它很容易進行，並且不僅可以提供有關尿路健康狀況的寶貴資訊，還可以提供有關整個身體健康狀況的寶貴資訊。尿液培養是一種識別導致尿道結石的特定細菌類型的測試，與藥敏測試一樣，可以幫助確定哪些抗生素對感染疾病最有效。在此過程中，將少量尿液樣本放置在促進細菌生長的培養基上，從而允許存在的任何細菌生長。 1 到 3 天后，實驗室技術人員測試培養物，看看是否有明顯的細菌生長。如果有生長，就可以識別細菌並將其與不同的抗生素進行比較，看看哪一種能有效殺死細菌。

最終用戶：在診斷實驗室進行尿道感染檢測以檢測細菌是否存在的巨大潛力

診斷實驗室是進行各種測試以診斷健康狀況（包括尿道結石）的專業設施。這些實驗室配備了先進的技術來檢測引起尿道感染的細菌和真菌的存在。它在準確檢測病原體方面發揮關鍵作用，這對於有效治療尿道結石至關重要。診斷實驗室提供各種服務，從簡單的尿液分析到更複雜的微生物培養和藥敏測試。從首次懷疑尿道結石到確認其存在，診斷實驗室發揮重要作用，從而促進及時、適當的治療。醫院是診斷和治療尿道結石的主要中心。醫院設有化驗室和影像科，對重症、複雜病例尿道結石的診斷特別有幫助。該醫院治療的患者範圍廣泛，包括需要立即治療的急性症狀患者、複雜尿道結石患者以及反覆感染的患者。醫院提供的全面護理包括診斷過程和後續治療，從抗生素治療到重症病例的手術介入。醫院在尿道結石例的管理中至關重要，這需要多學科方法，整合泌尿系統、腎臟科醫師和感染疾病專家的專業知識。腎臟內科診所專門從事腎臟相關疾病的治療和管理，包括可能影響腎功能的尿道結石。這些診所對於尿道結石尿道結石復發或對腎臟健康構成風險的患者非常重要。腎臟內科診所專注於全面的腎臟護理，並提供專門的診斷服務，以了解尿道結石對腎功能的影響。該診所為因尿道結石而面臨腎臟損害風險或遭受腎臟損害的患者提供專門護理和監測，解決感染疾病及其對腎臟健康的影響，從而確保制定有針對性的治療計劃。

區域洞察

由於人口老化以及人們對早期發現和治療重要性的認知不斷提高等因素，美洲尿道結石的盛行率很高，尤其是在北美。美國因其先進的醫療基礎設施、高昂的醫療成本和強大的市場參與企業而在該市場佔據重要地位。由於醫療基礎設施的改善和診斷測試的增加，南美市場也在穩步成長。亞太地區尿道結石檢測市場快速成長，主要歸功於人口的增加、醫療意識的提高以及醫療設施的進步。中國和印度等經濟體因其龐大的人口和完善的醫療保健系統而處於領先地位。該地區還受益於衛生基礎設施投資的增加以及能夠負擔先進衛生服務的中階的不斷壯大。歐洲是尿道結石檢測的成熟市場，其醫療水平較高，醫療保健體系完善，尿道結石防治意識廣泛。市場是由技術進步、醫療保健支出增加和政府支援措施所推動的。相比之下，中東和非洲的局勢則好壞參半。由於衛生支出的增加和衛生設施現代化的努力，波灣合作理事會（GCC）國家正在顯示出成長潛力。

FPNV定位矩陣

FPNV 定位矩陣對於評估尿道感染檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對尿道感染檢測市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該細分市場競爭特徵的寶貴見解，包括在研究基準年中觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動和突破性產品開發的智力見解。

本報告解決了以下關鍵問題：

1.尿道感染檢測市場規模及預測為何？

2.在尿道感染感染檢測市場的預測期內，我們應該考慮投資哪些產品和應用？

3.尿道感染感染檢測市場的技術趨勢和法規結構是什麼？

4.尿道感染感染檢測市場主要廠商的市場佔有率為何？

5. 進入尿道感染檢測市場的適當形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球尿道感染率增加
      • 抗生素過度使用和抗藥性增加導致複雜的尿道感染
    • 抑制因素
      • 尿道感染檢測解決方案產品回想問題
    • 機會
      • 加大新成像技術和檢測設備的開發力度
      • 政府為提高快速診斷所採取的有利舉措
    • 任務
      • 與尿道感染相關的社會恥辱
  • 市場區隔分析
    • 檢測：增加藥敏試驗的使用以避免開抗生素處方
    • 最終用戶：在診斷實驗室進行尿道感染檢測以檢測細菌是否存在的巨大潛力
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章尿道感染道感染檢測市場（依適應症）

  • 介紹
  • 膀胱炎
  • 腎盂腎炎
  • 尿道炎
  • 陰道炎

第7章尿道感染感染檢測市場：檢測套組

  • 介紹
  • 家庭檢測套組
  • 臨床檢測套組

第8章尿道感染感染檢測市場：按檢測

  • 介紹
  • 藥敏試驗
  • 尿液檢查
  • 尿液培養

第9章尿道感染道感染檢測市場：依最終用戶分類

  • 介紹
  • 診斷實驗室
  • 醫院
  • 腎臟病門診

第10章美洲尿道感染檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太尿道感染檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲尿道感染檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-7C50F27396DF

[193 Pages Report] The Urinary Tract Infection Testing Market size was estimated at USD 1.40 billion in 2023 and expected to reach USD 1.47 billion in 2024, at a CAGR 4.75% to reach USD 1.94 billion by 2030.

Urinary tract infection (UTI) testing includes a range of diagnostic procedures used to ascertain the presence of infection in the urinary tract, an essential part of the system that creates, stores, and removes urine from the body. This infection is primarily caused by microbes, including bacteria, viruses, and fungi, though bacteria are the most common cause. Testing for UTIs is critical because these infections can lead to severe discomfort, and if left untreated, potentially serious health complications. The increase in the number of urinary tract infections globally is expanding the need for urinary tract infection (UTI) testing solutions. Growing public awareness about the symptoms and risks associated with UTIs is creating a platform for urinary tract infection (UTI) testing solutions. The growing issue of antibiotic resistance and the high cost of UTI tests hampers the growth of the market. The rising development of rapid, reliable, and easy-to-use diagnostic tests that make UTI testing more accessible is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.40 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 1.94 billion
CAGR (%) 4.75%

Tests: Rising usage of susceptibility testing to avoid prescribing antibiotics

Susceptibility testing is a laboratory method used to determine the sensitivity of bacteria isolated from a UTI to different antibiotics. This test is crucial because it helps doctors choose the most effective antibiotic to treat the infection. By performing susceptibility testing, healthcare providers can avoid prescribing antibiotics that the bacteria are resistant to, thereby ensuring a more efficient treatment for the patient. Urinalysis is a quick and simple test that analyzes urine for the presence of certain indicators of infection or kidney disease. It involves examining the visual, chemical, and microscopic aspects of urine. This test can provide early signs of a UTI, such as the presence of white blood cells, red blood cells, bacteria, or substances including, nitrites, which some bacteria produce. Urinalysis is often the first test conducted when a UTI is suspected because it's easy to perform and provides valuable information about the body's overall health, not just the urinary tract. Urine culture is a test that identifies the specific type of bacteria causing the UTI and, similar to Susceptibility Testing, can help in determining which antibiotics will be most effective against the infection. In this process, a small sample of urine is placed on a culture medium that encourages the growth of bacteria and is then incubated to allow any bacteria present to multiply. After 1-3 days, the lab technicians examine the culture to see if there has been significant bacterial growth. If there is growth, they can identify the bacteria and test them against various antibiotics to see which one effectively kills the bacteria.

End User: High potential for urinary tract infection testing in diagnostic laboratories to detect the presence of bacteria

Diagnostic laboratories are specialized facilities where various tests are conducted to diagnose health conditions, including UTIs. These laboratories are equipped with advanced technology to detect the presence of bacteria or fungi that cause urinary tract infections. They play a crucial role in accurately detecting pathogens, which is essential for effectively treating UTIs. Diagnostic laboratories offer various services, from simple urine analysis to more complex microbiological culturing and sensitivity testing. They serve as a vital link between the initial suspicion of a UTI and the confirmation of its presence, thereby facilitating timely and appropriate treatment. Hospitals serve as primary centers for both the diagnosis and treatment of UTIs. They are equipped with in-house laboratories and imaging departments that assist in diagnosing UTIs, especially in severe or complicated cases. Hospitals cater to a broad spectrum of patients, including those with acute symptoms requiring immediate attention, individuals with complicated UTIs, and patients experiencing recurrent infections. The comprehensive care provided in hospitals includes both the diagnostic process and subsequent treatment, ranging from antibiotic therapy to surgical intervention in more severe cases. Hospitals are critical in managing UTI cases that necessitate a multidisciplinary approach, integrating the expertise of urologists, nephrologists, and infectious disease specialists. Nephrology clinics specialize in treating and managing kidney-related diseases, including UTIs that can potentially affect kidney function. These clinics are important for patients with recurrent UTIs or those with UTIs that pose a risk to renal health. Nephrology clinics focus on comprehensive kidney care, offering diagnostic services specifically to understand the impact of UTIs on kidney function. The clinics provide specialized care and monitoring for patients at risk of or suffering from kidney damage due to UTIs, ensuring targeted treatment plans that address both the infection and its implications on renal health.

Regional Insights

In the Americas, particularly in North America, there is a high prevalence of UTIs due to factors such as aging populations and a growing awareness of the importance of early detection and treatment. The United States holds a significant position in this market due to advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of market players. The South American market is also growing steadily, driven by improving healthcare infrastructure and increasing access to diagnostic testing. The APAC region is witnessing rapid growth in the UTI testing market, attributed mainly to the increasing population, rising healthcare awareness, and advancements in healthcare facilities. Economies such as China and India are at the forefront due to their large population bases and improving healthcare systems. The region also benefits from escalating investments in healthcare infrastructure and a growing middle class that can afford advanced healthcare services. Europe is a mature market for UTI testing, characterized by high healthcare standards, a well-established healthcare system, and widespread awareness about UTI prevention and treatment. The market is driven by technological advancements, an increase in healthcare spending, and supportive government initiatives. In contrast, the Middle East and Africa (MEA) present a mixed picture. The Gulf Cooperation Council (GCC) countries exhibit potential for growth due to increasing healthcare expenditure and initiatives to modernize healthcare facilities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Urinary Tract Infection Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urinary Tract Infection Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardinal Health Inc., Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., Piramal Pharma Limited, QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthineers, Stryker Corporation, SYSMEX CORPORATION, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Vivosens Inc..

Market Segmentation & Coverage

This research report categorizes the Urinary Tract Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Cystitis
    • Pyelonephritis
    • Urethritis
    • Vaginitis
  • Test Kits
    • Home Test Kits
    • Laboratory Test Kits
  • Tests
    • Susceptibility Testing
    • Urinalysis
    • Urine Cultures
  • End User
    • Diagnostic Laboratories
    • Hospitals
    • Nephropathy Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Urinary Tract Infection Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urinary Tract Infection Testing Market?

3. What are the technology trends and regulatory frameworks in the Urinary Tract Infection Testing Market?

4. What is the market share of the leading vendors in the Urinary Tract Infection Testing Market?

5. Which modes and strategic moves are suitable for entering the Urinary Tract Infection Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of urinary tract infections worldwide
      • 5.1.1.2. Complicated UTIs due to a rise in excessive use of antibiotics and drug resistance
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall issues with the urinary tract infection testing solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising development of new imaging technologies and testing devices
      • 5.1.3.2. Favorable initiatives by the government to increase rapid diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma concerning urinary tract infections
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Tests: Rising usage of susceptibility testing to avoid prescribing antibiotics
    • 5.2.2. End User: High potential for urinary tract infection testing in diagnostic laboratories to detect the presence of bacteria
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Urinary Tract Infection Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. Cystitis
  • 6.3. Pyelonephritis
  • 6.4. Urethritis
  • 6.5. Vaginitis

7. Urinary Tract Infection Testing Market, by Test Kits

  • 7.1. Introduction
  • 7.2. Home Test Kits
  • 7.3. Laboratory Test Kits

8. Urinary Tract Infection Testing Market, by Tests

  • 8.1. Introduction
  • 8.2. Susceptibility Testing
  • 8.3. Urinalysis
  • 8.4. Urine Cultures

9. Urinary Tract Infection Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals
  • 9.4. Nephropathy Clinics

10. Americas Urinary Tract Infection Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinary Tract Infection Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinary Tract Infection Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. PathogenDx's Eco-efficient D3 Array Platform Approach for Urinary Tract Infection Testing
    • 13.3.2. Vivoo Unveils Smart At-Home Testing Solution Advancing UTI Diagnostics
    • 13.3.3. A Novel Diagnostic Sensor Developed by University of Texas at Dallas Researchers
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEPHROPATHY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEPHROPATHY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)

TA